Anti-Neuroserpin Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibodies raised against the amino-terminal region of human Neuroserpin (SERPINI1), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
UniProt
Q99574
Size
100ug
Cat. #
RP2Neuroserpin

In stock

SKU
RP-Neuroserpin

Options

As low as: $130.00

Target Overview

Neuroserpin (SERPINI1, UniProt Q99574) is a secreted serine protease inhibitor of the serpin superfamily, predominantly expressed in the nervous system. The 410-amino acid protein functions as an inhibitor of tissue-type plasminogen activator (tPA) and plasmin, but does not inhibit thrombin. Neuroserpin is secreted by neurons and localizes to axonal pathways and synaptic regions during development and in the mature brain. Its primary role involves regulating extracellular proteolysis in neural tissue, particularly the tPA-plasmin system, which has been implicated in synaptic remodeling, learning, and memory. Neuroserpin may protect neurons from excitotoxic damage mediated by excessive tPA activity. Researchers study Neuroserpin in the context of neurodegenerative disease, synaptic plasticity, epilepsy, and a rare autosomal dominant dementia known as familial encephalopathy with neuroserpin inclusion bodies (FENIB), caused by polymerogenic mutations that lead to intracellular neuroserpin aggregation.

Background

Neuroserpin belongs to the clade I serpins and acts as a suicide substrate inhibitor, forming stable covalent complexes with target serine proteases. Its inhibitory activity toward tPA and plasmin positions it as a key regulator of extracellular matrix remodeling and cell migration in the central nervous system. During development, Neuroserpin expression correlates with periods of axon outgrowth and synaptogenesis, and in adults it is enriched in regions associated with synaptic plasticity such as the hippocampus and cortex. Dysregulation of the tPA-plasmin-neuroserpin axis has been implicated in neuronal injury, stroke, and neurodegenerative conditions including Alzheimer disease. Mutations in SERPINI1 cause FENIB, a progressive dementia characterized by intraneuronal accumulation of polymerized neuroserpin. The Ser52Arg variant is one such familial mutation; recent structural work has examined how small molecules like epigallocatechin gallate may reduce polymerization and preserve inhibitory function in this variant (Ahmad et al., 2026). Beyond neurodegeneration, Neuroserpin has been studied as a biomarker in psychiatric conditions, with altered serum levels reported in patients with bipolar disorder, potentially reflecting neuroimmune dysregulation (Ünver et al., 2026). The protease targets of neuroserpin, particularly plasmin, have also been implicated in non-neural contexts such as arthritis-associated pain, where plasmin activates proteinase-activated receptor-4 on sensory neurons (McDougall, 2026). Triple Point Biologics offers three rabbit polyclonal antibodies against Neuroserpin, each raised against the amino-terminal region of the human protein. These antibodies are validated for Western blot, with predicted cross-reactivity in mouse, rat, non-human primate, and dog.

References

  1. Ahmad T et al (2026) Structural targeting of a familial variant of neuroserpin (Ser52Arg) by epigallocatechin gallate binding that reduces polymerization and enhances the tissue plasminogen activator inhibition. Biochim Biophys Acta Proteins Proteom. PubMed · DOI
  2. Ünver H et al (2026) Neuroserpin, Tissue Plasminogen Activator, Brain-Derived Neurotrophic Factor and Interleukin-6 Serum Levels in Patients with Bipolar Disorder. Noro Psikiyatr Ars. PubMed · DOI
  3. McDougall JJ (2026) Plasmin contributes to arthritis pain by cleaving proteinase activated receptor-4 in rats. Neurosci Lett. PubMed · DOI
  4. Cherian A (2026) Progressive Myoclonic Epilepsies - A Pragmatic Review. Neurol India. PubMed · DOI
  5. Yang H (2026) Identification and Regulation of Common Key Genes in COPD and AD. Comb Chem High Throughput Screen. PubMed · DOI

Additional Specifications

Gene Symbol SERPINI1
UniProt ID Q99574
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Amino end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 17-67.
Immunogen (Mid molecule)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 150-250.
Immunogen (RCL shoulder)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 365-405.
Alternate Names SERPINI1, Serpin I1, Peptidase inhibitor 12, PI-12, Neuroserpin

Frequently Asked Questions

What molecular weight should I expect for Neuroserpin on a Western blot?

Neuroserpin (SERPINI1) runs at approximately 55 kDa on SDS-PAGE under reducing conditions, though the predicted molecular weight from the 410-amino acid sequence is around 46 kDa. The discrepancy reflects post-translational modifications, particularly N-glycosylation at three consensus sites. Depending on glycosylation status and tissue source, you may observe bands between 50-60 kDa. Neuronal lysates typically show the fully glycosylated form. Treatment with PNGase F or other deglycosylation enzymes will shift the band closer to the predicted 46 kDa, confirming identity if needed.

What is the recommended starting dilution for this Neuroserpin antibody in Western blot?

We recommend starting at 1:1000 dilution in blocking buffer for Western blot, based on validation with human neuronal lysates. This rabbit polyclonal typically provides clear signal at this dilution when detecting endogenous Neuroserpin in brain tissue or neuronal cell lines. If signal is weak, you can increase concentration to 1:500, though higher backgrounds may appear. For recombinant protein or overexpression models, 1:2000 to 1:5000 often suffices. Always include a negative control lacking Neuroserpin to confirm band specificity, as serpins share structural homology.

Does this antibody cross-react with mouse and rat Neuroserpin?

This antibody shows validated reactivity with human Neuroserpin and predicted cross-reactivity with mouse and rat based on sequence homology. Human and mouse Neuroserpin share approximately 85 percent amino acid identity, with conservation highest in the serpin domain. Rat homology is similarly high. We have not formally validated performance in rodent samples, so if working with mouse or rat brain tissue, plan to optimize dilution and include positive controls such as cortex or hippocampal lysate known to express Neuroserpin. Primate samples (monkey) are also predicted to cross-react given high sequence conservation.

What positive control tissue or cell line should I use for Neuroserpin detection?

Human brain cortex or hippocampus lysates serve as strong positive controls, as Neuroserpin is highly expressed in neurons of these regions. For cell lines, differentiated neuronal models such as SH-SY5Y (after differentiation with retinoic acid) or primary cortical neuron cultures express detectable endogenous Neuroserpin. Recombinant human Neuroserpin protein is also suitable for validating antibody recognition and confirming expected molecular weight. Avoid using HeLa, HEK293, or other non-neuronal lines as negative controls unless you verify low or absent expression by qPCR, since basal serpin expression patterns vary.

Can this antibody detect Neuroserpin polymers associated with FENIB disease?

This polyclonal antibody recognizes native Neuroserpin and should detect polymeric forms under non-reducing or semi-denaturing conditions, as epitopes within residues targeted by polyclonals often remain accessible in polymers. Familial encephalopathy with neuroserpin inclusion bodies (FENIB) results from mutations causing intracellular polymerization. To visualize polymers, run samples under non-reducing conditions or use native PAGE; high-molecular-weight species or smearing above the monomer band may appear. For inclusion body detection in tissue, immunohistochemistry or immunofluorescence on fixed brain sections is more informative than Western blot, and this antibody is validated for Western blot; IHC validation is in progress.

What sample preparation steps are critical for detecting secreted Neuroserpin?

Because Neuroserpin is secreted by neurons, you can detect it in both cell lysates and conditioned media. For lysates, use RIPA or similar buffer with protease inhibitors; avoid boiling samples excessively, as serpin structure can be sensitive to prolonged heat. For conditioned media, concentrate samples 10- to 20-fold using centrifugal filters (10 kDa cutoff) to improve detection, since secreted levels are often lower than intracellular pools. Include serum-free or low-serum culture conditions for at least 24 hours before collection to reduce albumin interference. Always include a loading control for media samples, such as Ponceau staining.

How should I store this Neuroserpin antibody and what is the shelf life?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The 100 µg pack size is suitable for dividing into 10-20 µL aliquots upon receipt. Rabbit polyclonal antibodies typically remain stable for at least two years at -20°C when stored properly. For short-term use (up to one month), you may keep a working aliquot at 4°C with 0.02 percent sodium azide as preservative. Avoid storing in frost-free freezers due to temperature cycling. If you observe precipitate after thawing, centrifuge briefly before use.

Does Neuroserpin require special blocking conditions to reduce background in Western blot?

Standard blocking with 5 percent non-fat dry milk in TBST for one hour at room temperature is usually sufficient for this rabbit polyclonal. However, if you observe high background, switch to 3-5 percent BSA in TBST, as milk proteins can sometimes cause non-specific binding with serpin antibodies. Ensure your neuronal lysates are fresh and protease inhibitors are included, since degraded samples increase background smearing. Extended blocking (overnight at 4°C) rarely improves signal-to-noise for this target. Including 0.05-0.1 percent Tween-20 in all wash steps helps reduce non-specific binding without compromising Neuroserpin detection.

Western blot validation for RP-Neuroserpin — 3 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Neuroserpin: Amino end — WB validation
WB · Panel 1 Neuroserpin: Amino end
Neuroserpin: Mid molecule — WB validation
WB · Panel 2 Neuroserpin: Mid molecule
Neuroserpin: RCL shoulder — WB validation
WB · Panel 3 Neuroserpin: RCL shoulder

Custom validation studies available on request — contact us.

Also known as:

  • SERPINI1
  • Serpin I1
  • Peptidase inhibitor 12
  • PI-12
  • Neuroserpin
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →